(Q67908017)
Statements
Six week safety study of 2% MK-927 administered twice daily to ocular hypertensive volunteers (English)
J. B. Serle
J. Lustgarten
E. A. Lippa
C. B. Camras
L. Framm
J. E. Payne
D. Deasy
1 January 1992
scientific article published on 01 January 1992